rethinkPeptides Search
Menu
Study breakdown

BNP and ANP for Heart Failure: Diagnostic and Prognostic Performance Compared

ReviewModerate evidence
The takeaway

BNP outperformed ANP for both diagnosing heart failure with systolic dysfunction and predicting outcomes, with NT-proBNP showing particularly strong prognostic value — a comprehensive evidence synthesis.

BNP wins both

BNP outperformed ANP for BOTH diagnosis AND prognosis in heart failure — definitively establishing it as the superior cardiac peptide marker

What the researchers found

BNP outperformed ANP for heart failure diagnosis (higher sensitivity/specificity) and prognosis, with NT-proBNP showing particularly strong prognostic value for predicting adverse cardiac events in LV systolic dysfunction.

Why it matters

This definitive comparison settles the BNP-vs-ANP debate: BNP/NT-proBNP should be the standard cardiac biomarker for both diagnosis and prognosis in heart failure.

How the study worked

Systematic review investigating the diagnostic and prognostic performance of plasma BNP and ANP in heart failure with LV systolic dysfunction across published clinical studies.

What this study cannot tell us

Systematic review dependent on published study quality. Some studies had small samples or heterogeneous heart failure populations.

How to read the evidence

Moderate evidence from a systematic review synthesizing diagnostic and prognostic data across multiple clinical studies.

When this study was published

Published in 2004. BNP/NT-proBNP has since become the global standard for heart failure biomarker testing.

The bigger picture

The BNP superiority demonstrated here drove the global adoption of BNP/NT-proBNP as the standard heart failure biomarker, now used in every major hospital worldwide.

Questions still open

  • Should ANP testing be abandoned in favor of BNP/NT-proBNP?
  • Is NT-proBNP better than BNP for prognosis?
  • Does combined BNP + ANP add value over BNP alone?

Common questions

Which heart failure blood test is best?
BNP or NT-proBNP — this systematic review definitively showed they outperform ANP for both diagnosing heart failure and predicting who will do poorly.
Are BNP and NT-proBNP the same?
They're different parts of the same precursor molecule. Both work well, with NT-proBNP showing slightly better prognostic performance. Most hospitals offer one or the other.

Read the original research

BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.

Journal of the renin-angiotensin-aldosterone system : JRAAS, 5(3), 121-9

Citation

Falcão, Luiz Menezes; Pinto, Fausto; Ravara, Luciano; van Zwieten, Peter Adriaan. (2004). BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.. Journal of the renin-angiotensin-aldosterone system : JRAAS, 5(3), 121-9.